[Aspergillosis. Clinical forms and treatment]
- PMID: 22341751
- DOI: 10.1016/j.eimc.2011.12.005
[Aspergillosis. Clinical forms and treatment]
Abstract
Invasive aspergillosis, chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis are the clinical forms of aspergillosis. Although there is a great number of Aspergillus species, Aspergillus fumigatus-complex is the more frequent aetiological agent, regardless of clinical form or baseline condition. The increase in immunosuppressive agents and the higher use of corticosteroids in chronic obstructive pulmonary disease have led to aspergillosis becoming more prominent in recent years. Galactomannan detection and radiological diagnostic images complement the limitations of microbiology cultures in these patients. Voriconazole and liposomal amphotericin B are the gold standard in patients requiring therapy, and posaconazole, itraconazole, caspofungin and other echinocandins are effective alternatives. The prognosis depends of clinical forms and characteristics of the host, but it is particularly poor in the disseminated invasive forms.
Copyright © 2011 Elsevier España, S.L. All rights reserved.
Similar articles
-
[Invasive aspergillosis with extrapulmonary involvement: pathogenesis, clinical characteristics and prognosis].Rev Iberoam Micol. 2012 Jul-Sep;29(3):139-43. doi: 10.1016/j.riam.2011.10.001. Epub 2011 Nov 20. Rev Iberoam Micol. 2012. PMID: 22108606 Spanish.
-
Discussion of case reports.Mycoses. 2010 Jul;53 Suppl 2:16-8. doi: 10.1111/j.1439-0507.2010.01912.x. Mycoses. 2010. PMID: 20591017 No abstract available.
-
Introduction to case reports.Mycoses. 2010 Jul;53 Suppl 2:1-2. doi: 10.1111/j.1439-0507.2010.01905.x. Mycoses. 2010. PMID: 20591010 No abstract available.
-
Invasive aspergillosis in developing countries.Med Mycol. 2011 Apr;49 Suppl 1:S35-47. doi: 10.3109/13693786.2010.505206. Epub 2010 Aug 18. Med Mycol. 2011. PMID: 20718613 Review.
-
Epidemiology of invasive aspergillosis and risk factors in non neutropaenic patients.Rev Mal Respir. 2010 Oct;27(8):e34-46. doi: 10.1016/j.rmr.2010.01.004. Epub 2010 May 15. Rev Mal Respir. 2010. PMID: 20965392 Review.
Cited by
-
Chronic Maxillary Sinusitis Caused by an Aspergilloma in the Context of Inadequately Treated Type II Diabetes Mellitus.In Vivo. 2023 May-Jun;37(3):1379-1383. doi: 10.21873/invivo.13220. In Vivo. 2023. PMID: 37103077 Free PMC article.
-
The Effect of Temperature over the Growth and Biofilm Formation of the Thermotolerant Aspergillus flavus.J Fungi (Basel). 2025 Jan 10;11(1):53. doi: 10.3390/jof11010053. J Fungi (Basel). 2025. PMID: 39852472 Free PMC article.
-
Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond.mBio. 2025 May 14;16(5):e0056225. doi: 10.1128/mbio.00562-25. Epub 2025 Apr 2. mBio. 2025. PMID: 40172196 Free PMC article. Review.
-
A 9-Year Experience of Aspergillus Infections from Isfahan, Iran.Infect Drug Resist. 2020 Jul 14;13:2301-2309. doi: 10.2147/IDR.S259162. eCollection 2020. Infect Drug Resist. 2020. PMID: 32765006 Free PMC article.
-
Cervico-Dorsal Intramedullary Spinal Cord Abscess with Aspergillus fumigates following Pulmonary Infection in an Immunocompetent Patient.Medicina (Kaunas). 2023 Apr 20;59(4):806. doi: 10.3390/medicina59040806. Medicina (Kaunas). 2023. PMID: 37109764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical